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Amended proposal for a 
EUROPEAN PARLIAMENT AND COUNCIL DECISION 
adopting a 
programme of  Community action 1999-2003 on rare diseases in the context of 
the framework for action in the field of public heaJth 
(presented by the Commission pursuant to Article 189 a (2) 
ofthe EC-Treaty) EXPLANATORY MEMORANDUM 
(I) The initial proposal for a European Parliament and Couneil decision adopting a 
programme of  Community action on rare diseases was adopted by the Commission on 
26 May 19971. 
(2) The Economic and Social Committee2 and the Committee oftheRegionsl 
delivered favourable opinions on this initial Commission proposal. 
(3) In the light of  the European Parliament's opinion after its first reading on 10 
March 1998 the Commission, in accordance with article l89a (2) of  the treaty, is now 
submitting an amended· proposal for a decision  .. The text inc)orporates arnencbrients that 
clarify and broaden the actions covered by the programme.·  .  . 
.  (4) .The European Parliament adopted 28 amendments of  which 16 can be accepted by 
the Commission: 1 in toto, 2 with slight rewording and 13 partially (matched with a 
modified proposition). 
(S) The 12 amendments which are not acceptable by the Commission can be grouped 
as follows :  · 
- 6 concern the recitals in the preamble ; 
- S concern the articles of  the decision ; 
''  '  .  '  . 
- I concerns the annex ; 
The reasons for rejecting. these 12 amendments are the following: 
-4 amendments are not aeceptablefor legal rell$0ns (6,  10, 20, 21); 
- I amendment falls outside the scope of  the programme ( 18) 
-3 amendments are unacceptably limiting (4, 15, 24) 
- 2 amendments are covered elsewhere (II, 13) 
... 2 amendments are unacceptable due tQ budgetacy limitations (14, 19). 
I  OJ N"C 0203 of03.07.97 . 
2  Opinion delivered on 29 October 1997, OJ N"C 19 21.1.98 
3  Opinion delivered on 20' November 1997, OJ N°C 64 27,2.98 Amended proposal for a European Parliament and Council Decision adopting a 
programme of  Community action 1999-2003 on rare diseases in the context of 
the fl'llllleWork for action in the field of  public health 
"<>; I 
THE EtJR.OPEAN PARLIAMENT AND 
THE  COtJNCR.  OF'  TBE. EURO:l'I:AN 
UNION 
Having reprcJ to the 1'rell.y estabti ....  the 
Ellropeln  Conmmity.  and.  in  partl(;uJar 
Article 129 thtnc(  -
Having  regard  to  the  proposal  &om  the 
Commission,  . 
Having regard to the opinion of  the~ 
and Social Committee.  . 
Having  regard  to  the  opinion  of  the 
Committee ofthe Regions,  -
Ac:tins .  in  acCordanc.e  with  the  procedure 
refemd_to in Article 189b of  the Treaty; 
1.  Whereas. the V«Y filet of  the rareness 
of the  low-pnMleoce  _diseases  and 
conditions and the Consequent lade of 
i11formation  about  them can  lead  to 
peoplo. atrected  by  these  conditions 
not receiving the bealth ~and 
seMces they need;  / 
.  . 
. 
2 
la) 
lb) 
. 
Having  regard  to the  proposal fi'om 
the Commission,~ 
Having ·regard to the apimon. of  the 
n~.-and C!-..:-1 ,.._  •  . 2 
WIU\A....  .  - U)l!llllltee, 
Having regard  to-the opinion· of  the 
Committee of  the Re8ions. 
3 
. 
Whereas CoiiJDJUIJity eTogs dlould 
be dfected toms t)le  J)l!M!!Df;ion 
of diseases  ami  whereas  actiQn  by 
the CQnmuw 9111  provide unip 
eMod valuf  to tJtik'inl  Ptnbkml 
:n=ii~w:n~=~ 
""¢"MIX lliJilnis or Rn>Jw·actloiJ! 
Whereas  tbe  nnmhc;c  of people 
affected-by iu,diyidual rare  ctiseaMJ  · 
. IDlY. . by  dcfjnjtj.on.  .  be  -mletjyobr 
IIDI11  but whereas the IIITOJIIion 
of aU .  JHrtienb  VJit1t.  rare di•r 
amoupts to a sv!magtjel nvmbcrr jn 
thepnprrbttjw  · 
I. OIN" C 203 fll03.0'7.97 
2. OJ  No c 19 of21.01.118 
3"  OJ  N" c 64 of27.02.98 
. 2. 
3. 
Wberas,  for  the  purposes  of this 
programme  rare  diseases  wiD  be 
defined  as  life..threatening  or 
chronically debilitating diseases whim 
are  of such  low  prevalence  that 
special combined efforts are needed to 
address them;. 
Whereas, in accordance with point (  o) 
of  Article 3 of  the Treaty, Conununity 
action  sball  include  contribution 
towards the attainment of  a high level 
ofhealth protection; 
4.  Whereas  Article  129  expressly 
provides for Community competence 
in this field in so tar as the Community 
contributes to it by  encouraging  co-
operation between the Member States 
and, if  necessa'Y,  lending support  to 
their action;  promoting co-ordination 
of  their policies and programmes, and 
fostering · co-operation  with  third 
countries  and  international 
organisations competent in the sphere 
of  public health; whereas Community 
action should be directed towards the 
prevention  of  diseases,  and  the 
promotion  of health  education  and 
infori118tion; 
3 
0 
lc) 
andtheirfimilies: 
2a) 
to become more frequent: 
• 
I ..  .. 
0 
S.  Whereas  rare  diseases  have  been  S. 
identified  as  a  .priority  area  for 
Comnnmity  action  within>  the 
framework for action  ~  the  field  of 
public bealthl 
Sa) 
6.  Whereas  . in  its  Resolution  (A4- -Ei. 
0311/95) on the Medium-Term Social 
Action  Programme  l99S-199T  the 
·  ParW!ment asked  the Commission to 
present, under the proper~ 
··the  action  -~  for  rare 
diseases foreseen in the Commission's 
trameWork  COil'II1UUJicaton  on public 
health;  .  .  . 
7.  Whereas,  in  .accordanCe  with  the 
principle  of subsidiarity,  acdon  on 
matters  not  under  the  exclusive 
competence of the ComniJnity,  IUCb 
as  acdon on  rare diseases  must be 
undertaken by the~  only if 
and in so fir  as, by reason of  its scale 
or effec;ts, it may be better  acbievecl 
at Comn1unity level;  . 
I. COM(93)5~11nol 
2. OJN" c  32 af05.02.96 
4 
' 
WbcRas  181'8  diseases  have  been 
identified  as  a  priority  -. for 
ComniJnity  action  within  the. 
hmework for action in the field  of 
public healtiJf  .  . 
Whereas  a  JIPIIJ'!UD'I  of 
Community action ·on qre djw• 
nmst be ypdrmJrm  u  a part ofa 
coberegt  strltml.v  ..  whicb . ilso 
jncludes  proyjajnn•  ·  ·  roc · omtvm  · 
medigiul product& end tesCIJliA on 
rare  diseases  and·  whereas·  a 
· Community  · detahenk  ·.  should  -b$; 
.  compiled  . to  . store  .. QlHJatM 
jnfimnation  on  rare  <li•• JDd 
whereas  detectjon  ·  •pd  .·  .·  ptm1 
systems should ljkewjHJ be set up: 
. Whereas  in  ita  Resolution  .  (A4-
0311/9S) on the Mecfiwn..  Term Social 
Action  Programme  .199S-t99']J  the 
Parliament  asked.· the COm.nission to 
present, under the proper· proocdures; 
the  action  prosrurime  for.  .  rare 
diseases foreseen in the Copunission's 
fiameworlc ~  Oil J)Ublic 
health; 
...  . 
CON(93) ,,  .... 
5. QJ)ioC32.to5.02.96 8.  Whereas, the Conmmity can-provide 
added value to the actions ofMember 
States  -conceming  rare  diseases. 
through  the  - co-ordination  -of 
national11'lea8\U'eS, the dissemination 
of information and experiences,  the 
joint establishment of priorities, the 
development  of  networking  as 
appropriate,  selection  of European 
Community-wide  projects  and  the 
motivation  and  mobilisation  of all 
inv~; 
9.  Wben:as  co-operation  with  the 
international  cqanisations competent 
.in tbe field of  public health and with 
tbird c:ountries sliould be fostered; 
10.  Whereas,  by  providing  support  tbr 
acquiring  better  knowledge  and 
understanding  ot:  and  wider 
dissemination  of information  about 
rare  diseases  and  by  developing 
actions  complementaly  to  existing 
Conmmity programmes and actions, 
while  avoiding  unnecessaJy 
duplication,  the  programme  wiD 
contnDute to the achievement of  the 
Community  objectives  set  out  in 
Article 129; 
s 
Sa) 
lOa) 
_, 
'  I 11.  Wliereas,  in  order  to  increase  the , 
. value m:l impact of  the prosramme, a 
~·assessmeot:  of·the 8Cltions 
unclertakal  abould  be  autied  .  out, 
with . particular  regild  .  to .  their 
etrectiwness  and  the· achievement  of 
the  objectives· set  and,· with  a view 
where · appropriate.  to  making  the 
Deoe$SIJ}'~ 
Wheteas this progranune Should be of 
five.:year .cfuration  in order  to aDow 
sufficient  time  for  actions  tO  be 
implanented, to~  the obje,ctives 
set; 
13.  ~  the  introduction of ~c 
Community anangements wiD help to 
ensure  that  aD  .  Member  States. are 
swiftly ·  infonned  in. the  event  of an 
emergency·  si~  so  that  the 
protection  of the'~populati9ft .tal be 
enancl;. 
14. 
15.  ~  an  agreemellt on  a modus 
viVendi  -~- the  EuropeaJi  l 
Parliament,  the  Council  'IJ!d  _.·  the  -
ComrDission concerning measures for 
the  implementati~ of acts  adopted . 
under  the  proc:el.1tQ'e  laid  down  in 
-- Article  l89b  ·of  the  Treaty 
I  .  . 
reaehed on 20 December 1994. 
6 . 
. 
. 
16.  Whereas  this decision  lays  down,  a 
financial  framework  constituting  the 
prindpal point of  reference. within the 
JDellllills of  point 1 of the Declaration 
of  the  European  Parliament,  ·the 
Council  and  the  Commission  of 6 
March  1995,  for  the  budgetary 
authority during the annual budgetary 
procedure; 
17.  Whereas the Community's tinanclal 
perspective  is  valid  up  until .1999 
and will have to be revised for  the 
period beyond that date; 
18. 
. 
Whereas the  financial  frameworlc  for 
the last .four yean of  the prosramme 
(20()0..2003) aball be determined aft« 
the.  establisbment  of  the  future 
financial~ 
HAVE D~ED  AS FOU..OWS: 
1. 
2. 
Artiele 1 
. Establilhmeut of  the programme 
A programme of Community  action  . 
on rare diseases hereinafter referted to 
u  "this  progrunme•,  is  heRby 
adopted for the period 1Jmialy 1999 
to 31  December 2003 in the context 
of the  ftamework  for  action  in  the 
field .ofpub&c health. 
The  aim  of this  programme  is  to  2. 
contribute  towards  ensuring  a  high 
leve1 ofhealtb protection in relation to 
rare diseases by providing knowledge 
about  these  diseases  by  promoting 
and  strengtbeniog  patient  support 
groups and by fostering the setting up 
of  cluster response teams. 
3.  'fhe actions to be implemented under 
this  111'  and  their  .... 
7 
.  . 
I 
The  aim  of this  programme  is  to 
contn'bute .  towards ensuring  a high 
level of  health protection in relation 
to  rare  diseases  by  providing 
knowledge  about  these  diseases, 
egcially for  patients  and  health 
professionals.  by  promoting  and 
strengthening  patient  support 
groups, and by fostering the setting 
up of  cluster response teams. 
• objecdves  are ·set  out in  the  .Atlnex 
under the Nldinp:  . 
1)  Actions ·on  Cotnmunity  infOrmation 
on rue diaeaaes 
2) 
3) 
Adioos  in  IRlppOit  of padent  and 
fiamily IRlppOit groups  • 
Aaioas  on  baM!ing  rare  diseases  3) 
c:lusten. 
' -
Artidel 
ImPlementation  . 
The  Commission  shall  ensure 
impl~  in  close  co-operation 
with the Mermec ~·or  the actions set 
out in the Annex. 
2.  The CoiDIDismon shall eo:-operate with 
institutions and  ~sations  active in  · 
the field of  rare diseases. 
Anide3 
Budget 
1.  The  financial  frameWork  for  the 
implementation  of the  programme 
for the year 1999 shall be BCU 1,3 
Million,  in  keeping · with  current 
financial  ~ves.  The financial 
framework for the final. four years of 
the programme (2000-2003) sball be 
determined  in  detail  after · the 
establishment of the future  financial 
perspectiyes. 
2.  The  annual  appropriations  shall  be 
established.  by  the  BudgetaJy 
Authority  in  accordance  with  the 
financial 
&:tjona em, jdmd\'ina 1ppdJinr ""' 
Te!Q)9!ldins  rapjdly to rp di•= 
glnstm, Article4 
Consistency and complementarity 
The  ('.ommjssjon  shall  eosure  that  there  is 
c:onsisteocy and complementarity between the 
Community actions to be implemented under 
this programme and tbose implemented under 
other  relevant  CommuDity  programmes  llld 
actions. 
Article 5 
Committee 
1.  In implementing this action  plan,  the  I. 
Commission  sba1l  be  assisted  by  an 
advisory  committee,  hereinafter 
refelred  to  as  "the  Committee", 
consisting of  two representatives from 
each  Member ·State,  and  chaired  by 
die Commission representative. 
2.  The representative of  the Commission 
.  shaD submit to the Committee a draft 
of  the  measures  to  be  takeo 
concerning, in partiaJiar: 
(a)  . the  criteria,  and  procedures  for 
selecting and financing projects under 
this programme; 
(b)  the evaluation procedure. 
The Committee sba1l deliver its opinion on the 
draft,  within  a  time  limit  which  the 
chairperson may lay  doWn according to the 
urgency of  the matter, if  :necessary by taking a 
vote. 
The opinion sba1l be recorded in the minutes; 
in addition, each Member State shall have the 
right  to ask to have its position recorded in 
the minutes. 
9 
In implementing this action plan,  tt e 
Commission  shall  be  assi~ by  e  ~ 
advisory  committee,  hereinaft  1r 
referred  to  as  "the  Committee , 
consisting  of  lfWe.  • 
from each Member State, and  -L  • 
by the Commission representative. 
•  Ccmctian aflhe text ....  to  ..........  iD the E'.llalilb 
wnioa af1he pnlpCIIIl COM(97) 225 final 
'' The  Commission  sbill  take  the  utmost 
account  of the.  opinion  cleliwnld  by  the 
~.  It  abaD intbnn the Committee on 
the  ID8IIIW  in wbidl  its  opinion  has Deco 
taken into ICCOUDt. 
The  repl'tSentative  of  the  Commission  shaD 
keep the Committee regularly iDfbnned about 
Commission  proposals  or  Community 
initiatives  and  the  . impJemeotatiou  of 
programmes in c$er palicy areal which  are 
relevant to the acbievemeot Of the objectives 
of  this programme. 
Article6 
International co-operation 
1.  In  the  course  of in1plementiog  this 
programme,  co-operation  with  third 
countries  . end  with  international 
.  organisations competent in the field of 
public health shall be tbstenld. 
. 2.  This  programme  shall  be  open  to 
participation  by  the  associated. 
countries of  Central Europe (CEC), in 
accordance  with  the  conditions  laid 
down in the Association  Agreements 
or Aiiditiona1 Protocols related thereto 
concening  participatioll  in 
Community  programmes.  This 
programme  shaD  be  open  to 
participation by Cyprus and Malta on 
the basis of additi9DII appropriations 
in accordance ·with the same niles as 
those applied to the EFTA countries, 
.  in accordance  with .  procedures to be 
agreed with those countries. 
Artide7 
Monitoring and evaluation 
l.  In  the  implementation  of  this 
Decision. the Commission shall take 
the  neces  measures  to  ensure 
10 
'  ' 
' 
Till the  monitoring  and  continuous 
evaluation ofthe programme taking 
account or  the general  and  specific 
objectives  refenecl  to  in  Article 1 
and in the Annex. 
2.  . During  the  third  year  or  this 
programme,  the  Commission  sba1l 
present to the European Parliament 
and  to  the  Council  an  evaluation 
report 
3.  The Commission sba1l submit to the 
European  Parliament  and  the 
Council a final report on completion 
ortbis programme. 
4~  The  Commission  sba1l  incorporate 
into  these  two  reports  infonnation 
on  Community  financing  in  the 
various  fields  or action  and  on 
complementarity  with  the  other 
actions  ret'erred  to  in  Article 4,  u 
well  u  the  results  of  the 
evaluations. It sba1l  also ~  them 
to  the  Economic  and  Social 
Committee  and  the  Committee  ot 
the Regions. 
Done at Brussels, 
For the European Parliament 
For the Council 
The President 
The President. 
ANNEX 
SPECIFIC OBJECI'IVES AND 
·ACJlQNS 
1  AcriONS  ON  COMMUNITY 
INFORMATION ON RARE DISEASES 
Objective:  to provide knowledge about rare  Objective : 
diseases  especially  for  patients, 
health  professionals  and 
researchers. 
11 
·I--
to provide knowledge about rare 
diseases especially for patients 11¥1 
their reJatiyes. ·health professionals 
and researchers. ·-.f 
1.  F.ncourasement  and  support  for. the  1.· 
establishment  of  a  European  rare 
diseasC:s  database, with entries  listing 
the disease name,. synonyms, .a geoetal 
desaiption of  the dUiOrder, symptoms, 
causes.  affected  populati.on,  standard 
treatments,·  iiMlstigationll  treatments 
(when available) aud alist of  resources 
that  can  be  contacted  ·fur  further 
information about the condition. 
2.  Promoting access to inforination and 
co-ordinating  existiDs  information. 
systems and services by supporting the 
setting  up  and  strengthening  eX 
networks  at  local,  regional,  national 
and COilllriunity level. 
3.  Organising consensus meeti"&' among 
health  professionlls.  in  order.  to 
improve  the  early  detection, 
~  interVention  .  and 
~eption  of  rare diseases. 
D.  .ACDONS  IN  SUPPORT.  OF' 
PATIENT AND FAMILY  SUPPORT 
GROUPS 
'  . 
Objective:  to  establish,  fOster  and 
straJgthen ~organisations  involved in 
supporting  people  directly  or  indirectly 
affected by rare diseases; 
Promoting the e&fablisbment of  groups 
of.  persons  ·with  the · same  rare 
. conditions  or  those  professiooally 
involved in order to disseminate their 
to &cilitate  . •  and to 
12 
Encouragemeot  and. support  for the  ~ 
estabJisbmeot-'-of a  Emopean. ·rare 
dis  databa  with . •  .........  ·- listing'  seases  ...se,  .,..  ..  _ 
the disease name,· synonyms, a  general  · 
description  of  the  disorder, 
symptoms,  causes.  affected 
pOpulation,  standard  treatments, 
inveldptional  . treatments  (when 
available) and a list of~  that 
can  be  contacted  for  further 
intbnnation about ·the condition. l1Ja 
jnfhrmetjQD  coJlected  in ·  the  central 
Fnrqpm ,.se described  above 
will be  made  as  widely  availah)§  as 
possible. 
111IT co-ordinate their activities at national 
and Comrmmity level. 
S.  Promoting  the  groups'  conaboration 
and networkins and the setting up and 
fostering of~  bodies, focusing 
partiallarly  on  efforts  to  encourage 
the  contimJity  of work  and  cross-
national co-operation. 
DL  ACDONS  ON  HANDLING 
RARE DISEASES CLUSTERS 
Objective:  to ensure an efficient handling of  Objective : 
the problem of  clusters,  which is 
6. 
of  key  importance  for  rare 
diseases. 
Supporting  the  monitoring  (sentinel)  6. 
of  rare  disea~s,  including  birth 
defects,  genetic disorders or diseases 
of different  organ  systems  and  the 
appropriate.  techniques  for  low-
prevalence diseases,  in order to meet 
on  the  one  band  the  demands  of 
detection, treatment and research and 
on  the  other  hand  the  demands  of 
relevant statistical monitoring. 
7.  Promoting  the  <nation  of  rare  7. 
diseases  response  teams  and  of 
specialised training  courses  for  those 
investigating clusters. 
8.  Supporting  surveillance  and  early 
warning systems for clusters. 
9.  Encouraging the exchange of  expertise 
in  the  evaluation,  assessment, 
communication  and  management  of 
clusters  of rare  diseases  that  are 
associated with exogenic causes. 
13 
. including  defects, 
disorders  or  diseases  of  diffi:t'e4t 
organ  systems  and  the  approp · 
techniques  for  low-preval 
diseases, in order to meet on the o 
band  the  demands  of  detectio 
treatment  and  research  and  on 
other band  the demands  of rei 
statistical ~ring. 
I 
· handling of  clusters. I; 
h 
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